Cajolo, Ritchel B.

HRN: 27-34-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2025
CEFUROXIME 1.5GM (VIAL)
07/07/2025
07/08/2025
IVT
1.5g
PTOR
For Elective USO
Remove - Pending Acceptance
07/08/2025
CEFUROXIME 1.5GM (VIAL)
07/08/2025
07/14/2025
IV
1.5g
Q8
Pelvic Lap
Waiting Final Action 
07/08/2025
CEFUROXIME 500MG (TAB)
07/09/2025
07/15/2025
PO
500mg
Bid
Pelvic Lap
Remove - Pending Acceptance
07/09/2025
MUPIROCIN 2%, 15G (TUBE)
07/09/2025
07/15/2025
TOPICAL
Apply Liberally
OD
S/P USO
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: